CG Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

CG Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.96M	Sell	27,125 -4,315	-14%	-$481K	1.1%	28
2016 Q3	$3.82M	Sell	31,440 -3,020	-9%	-$407K	1.43%	19
2016 Q2	$4.87M	Buy	34,460 +6,840	+25%	+$1.01M	1.95%	12
2016 Q1	$3.61M	Sell	27,620 -4,460	-14%	-$555K	1.44%	21
2015 Q4	$4.51M	Sell	32,080 -5,120	-14%	-$709K	1.79%	15
2015 Q3	$4.94M	Sell	37,200 -3,035	-8%	-$523K	2.09%	13
2015 Q2	$7.08M	Buy	40,235 +1,925	+5%	+$346K	2.7%	8
2015 Q1	$6.62M	Buy	38,310 +790	+2%	+$136K	2.57%	7
2014 Q4	$6.14M	Buy	37,520 +565	+2%	+$93.8K	2.42%	7
2014 Q3	$5.93M	Buy	36,955 +5,010	+16%	+$770K	2.44%	6
2014 Q2	$4.7M	Sell	31,945 -2,850	-8%	-$395K	1.99%	13
2014 Q1	$4.83M	Buy	34,795 +700	+2%	+$105K	2.17%	9
2013 Q4	$4.32M	Buy	+34,095	New	+$3.53M	1.98%	11

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CG Asset Management's JAZZ Position: Q4 2016 in Review

CG Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 14% in Q4 2016, selling an estimated $481K and leaving 27,125 shares worth $2.96M. The position accounts for 1.1% of the portfolio, ranked #28.

CG Asset Management first reported a position in JAZZ in Q4 2013 and has held it in 13 quarters since. The position peaked at $7.08M in Q2 2015. 295 funds tracked by Wall St. Rank hold JAZZ as of Q4 2016.

CG Asset Management held 27,125 shares of Jazz Pharmaceuticals worth $2.96M as of Q4 2016.
CG Asset Management sold 4,315 Jazz Pharmaceuticals shares in Q4 2016, an estimated $481K.
Jazz Pharmaceuticals made up 1.1% of CG Asset Management's portfolio in Q4 2016, its #28 holding.
CG Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 13 quarters since.
CG Asset Management's Jazz Pharmaceuticals position peaked at $7.08M in Q2 2015.
295 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.